So basically, if you have a diabetic patient with high ischemic risk, long term monotherapy with Plavix, after standard dual antiplatelet therapy, may provide lower ischemic events compared with aspirin only with similar bleeding rates.
I have observed this in practice too.
Congratulations to JACC Interv on great paper
👇
🆕 ACC/AHA Guideline on the Management of Dyslipidemia offers a comprehensive “one-stop shop” for addressing the evaluation, management & monitoring of individuals w/ dyslipidemias.
Read the full guideline in #JACC: https://t.co/rhUKNIRRL4 #cvLipids#ClinicalGuidelines
FINEARTS-HF: Finerenone was associated w/ higher rates of post-baseline systolic BP <100 mm Hg & investigator-reported hypotension & had no significant difference in treatment effect based on baseline kidney function.
Get details ➡️ https://t.co/YXJqouVkT3 #JACCHF#HeartFailure
Meta-analysis of four randomized trials found β-blockers did not reduce mortality, recurrent #MyocardialInfarction (MI), heart failure, or revascularization in patients with preserved left ventricular ejection fraction after MI. https://t.co/KZrArvkwIM
Key updates in valvular heart disease management: insights from the 2025 ESC/EACTS Guidelines
🔗https://t.co/w3oQ4sKFyG
@Sticchi_Alex provides his take ✍️on what's new & hot in the new VHD Guidelines!
#interventionalcardiology
In patients with cardiogenic shock who required invasive mechanical ventilation, rates of failed extubation were similar to patients with other critical illnesses, according to a study published in #JACCAdvances.
Read more: https://t.co/xvtfUqln7v